You've been automatically redirected here from Humanzyme.com, which is now part of Proteintech Group. Click here to dismiss this alert.

Company Profile

PROTEINTECH GROUP:
FOR SCIENTISTS, BY SCIENTISTS

As a company founded by scientists, Proteintech Group recognises the tireless efforts and sacrifices made by researchers to advance scientific discovery.
Proteintech aims to match its’ customers’ dedication to research by providing high quality, reliable reagents that contribute to reproducible results.

Find out exactly how Proteintech antibodies help our customers accelerate their research by watching this video.

ORIGINAL MANUFACTURER
ORIGINAL PRODUCTS

Part of Proteintech Group's early vision was to make all its own products, to the highest standards possible, thus assuming ultimate responsibility for their quality. In addition to its founders' refusal to source a single antibody from any other provider, they also refused to supply any other provider. This approach would offer researchers many advantages, including a way of avoiding the same antibodies sold under different brand names by different companies – an unregulated practice that still continues within the industry.


Ultimately, the 'Original Manufacturer' approach laid out by Proteintech's founders would contribute to an increasing sense of accountability in the antibody industry.

MISSION STATEMENT

One of its original founders and current
CEO Dr. Jason Li says of the reasons behind Proteintech's establishment:


"At the heart of our aspiration was a company for scientists by scientists; an antibody provider that would offer researchers the advantage — not investors."

Proteintech Milestones

  • 2002

    Proteintech is founded

  • August 2003

    First publication with a pre-made antibody (Recoverin antibody – 10073-1-AP, Kicic et al. Journal of Neuroscience)

  • 2004

    Chinese office opens in Wuhan and 100th antibody is manufactured

  • April 2006

    First monoclonal antibody goes on sale

  • 2007

    European office opens in Manchester and a Proteintech product features in a publication for the 50th time (Wang et al, Cell)

  • 2008

    Proteintech product features in a publication for the 100th time (Zhang et al, Blood)

  • 2010

    Proteintech features in a publication for the 1000th time (Nature Cell Biology)

  • March 3 2012

    First ELISA kit goes on sale and European Office obtains ISO9001 certification

  • 2013

    New lab facilities are opened and a Proteintech product features in a publication for the 5,000th time

  • 2014

    Proteintech labs obtain SPF (specific pathogen free) grade Mouse house certification. Production ISO9001 and ISO13485 certification also obtained

  • January 2015

    Launch of in-house RNAi validation department and a Proteintech product features in a publication for the 10,000th time

  • 2018

    Proteintech acquires Humanzyme, manufacturer of human-cell expressed proteins.

  • 2019

    Launch of 500+ antibodies directly conjugated with high-performance CoraLite®488, CoraLite®594 and CoraLite®647 dyes.

  • 2020

    Proteintech’s HumanKine® cytokines and growth factors now available in GMP-compliant versions for use in clinical trials and commercial manufacturing.

  • 2020

    Proteintech acquires ChromoTek, the market leader in nanobodies — high-performance recombinant reagents used for breakthrough research discoveries.

  • Present

    Proteintech's growing catalog of antibodies against 13,000 targets is now available in 39 countries across 5 continents with over 70,000 citations.

Proteintech Milestones

2002

Proteintech is founded

August 2003

First publication with a pre-made antibody (Recoverin antibody – 10073-1-AP, Kicic et al. Journal of Neuroscience)

2004

Chinese office opens in Wuhan and 100th antibody is manufactured

April 2006

First monoclonal antibody goes on sale

2007

European office opens in Manchester and a Proteintech product features in a publication for the 50th time (Wang et al, Cell)

2008

Proteintech product features in a publication for the 100th time (Zhang et al, Blood)

2010

Proteintech features in a publication for the 1000th time (Nature Cell Biology)

March 3 2012

First ELISA kit goes on sale and European Office obtains ISO9001 certification

2013

New lab facilities are opened and a Proteintech product features in a publication for the 5,000th time

2014

Proteintech labs obtain SPF (specific pathogen free) grade Mouse house certification. Production ISO9001 and ISO13485 certification also obtained

January 2015

Launch of in-house RNAi validation department and a Proteintech product features in a publication for the 10,000th time

2018

Proteintech acquires Humanzyme, manufacturer of human-cell expressed proteins.

2019

Launch of 500+ antibodies directly conjugated with high-performance CoraLite®488, CoraLite®594 and CoraLite®647 dyes.

2020

Proteintech’s HumanKine® cytokines and growth factors now available in GMP-compliant versions for use in clinical trials and commercial manufacturing.

2020

Proteintech acquires ChromoTek, the market leader in nanobodies — high-performance recombinant reagents used for breakthrough research discoveries.

Present

Proteintech's growing catalog of antibodies against 13,000 targets is now available in 39 countries across 5 continents with over 70,000 citations.


Back
to top